Treatment with AD-related oligomers of the amyloid β peptide (Aβo) further enhanced TLR4 expression, Ca2+ responses induced by LPS and neuron cell death, suggesting the interplay between TLR4 and Aβo in neuron cell death associated to aging and AD. Here, ABO is linked to Alzheimer disease.